Home
Search
BIO Digital

Speakers & Presenters

Meet the experts speaking on our world-class education program.

June 8-12, 2020
Register
Search
Event Menu
Event Menu
Search General Info
Search Education
Search Partnering Companies

2020 BIO Digital Education Program

New speakers and presenters confirmed regularly, so check back frequently for updates.

Featured Speakers
Dr. Fauci
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
ANTHONY S. FAUCI, MD is director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health,…
Paul Stoffels
Paul Stoffels, MD
VICE CHAIRMAN OF THE EXECUTIVE COMMITTEE AND CHIEF SCIENTIFIC OFFICER, JOHNSON & JOHNSON
Paul Stoffels is a visionary leader who inspires and drives transformational innovation to bring years of life and quality of life to millions of…
Sharon Chan
Sharon Chan, MBA, MPH, D. Phil
HEAD JLABS @ SHANGHAI, JOHNSON & JOHNSON INNOVATION
Sharon Chan is the Head of JLABS @ Shanghai. In this role, Sharon is responsible for setting the strategic direction and overseeing all operational…
Dr. Fauci
Paul Stoffels
Sharon Chan
All Speakers
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
By Count | Alphabetical
  • Show All
Company Type
Main Therapeutic Focus
Development Phase of Primary Product
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Stephen M. Hahn, MD
COMMISSIONER OF FOOD AND DRUGS, U.S. FOOD AND DRUG ADMINISTRATION
Fireside Chat with FDA Commissioner Dr. Stephen M. Hahn
photo
Christian Haas-Kwon
LIFE SCIENCE R&D ENABLEMENT LEAD, BENCHLING
Benchling
San Francisco, California, United States
photo
Kyung soo Hahm
DIRECTOR, BIOLEADERS
BioLeaders
Yongin-si, Korea - South Korea
photo
Todd Haim, PhD
CHIEF, OFFICE OF SMALL BUSINESS RESEARCH, NIH/NIA
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Bethesda, Maryland, United States
photo
William Hait, MD, PhD
GLOBAL HEAD, JOHNSON & JOHNSON EXTERNAL INNOVATION, JOHNSON & JOHNSON
Nature Biotechnology and Scientific American WORLDVIEW: Whiplash! How COVID-19 Will Radically Change Biomedical R&D Across the Globe
New Brunswick, New Jersey, United States
photo
Marian Hajduch
ASSOCIATE PROFESSOR, IMTM
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Olomouc, Czech Republic
photo
Jeff Haley
DEVELOPMENT, CELANESE
Celanese
Florence, Kentucky, United States
photo
Sonia Hall, PhD
PRESIDENT & CHIEF EXECUTIVE OFFICER, BIOKANSAS
Bioscience Professional Toolkit - How to successfully transition to a post-academic career
Shawnee, Kansas, United States
photo
Laurie Halloran
CHIEF EXECUTIVE OFFICER, HALLORAN CONSULTING GROUP
'N of Few' - Clinical Trial Design for Small Cohorts
Boston, Massachusetts, United States
photo
Reza Halse, PhD
HEAD, PACIFIC BD&L HUB AND PRESIDENT, MRL VENTURES FUND, MERCK
Merck
South San Francisco, California, United States
photo
Aldric Hama
DIRECTOR, HAMAMATSU PHARMA RESEARCH, INC.
Hamamatsu Pharma Research, Inc.
Hamamatsu, Japan
photo
Grace Han McMahon
HEAD OF TRANSACTIONS, BUSINESS DEVELOPMENT & LICENSING PACIFIC INNOVATION HUB, MERCK
GETTING IT 'JUST RIGHT': The Goldilocks Strategy for Effective and Efficient IP Due Diligence Processes
South San Francisco, California, United States
photo
Susie Harborth
CHIEF FINANCIAL OFFICER & ADMINISTRATIVE PARTNER, MISSION BIOCAPITAL
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
photo
David Harel
CO-FOUNDER AND CEO, CYTOREASON
CytoReason
Tel Aviv, Israel
photo
Robert Hariri, MD, PhD
CEO, CELULARITY
Natural Killer (NK) Cells: Pushing the Next Wave of Immuno-oncology Therapies
Warren, New Jersey, United States
photo
Meghan Harpole
NURSE, COVID-19 PATIENT
Understanding the Voices of Patients: Unique Perspectives on Healthcare
photo
Beverly Harrison
HEAD, PATIENT STRATEGIES & SOLUTIONS, JANSSEN
Activating the Value of RWD/RWE in a COVID-19 World
Titusville, New Jersey, United States
photo
Christine Harrison
VICE PRESIDENT, PUBLIC AFFAIRS AND STAKEHOLDER ENGAGEMENT, ORCHARD THERAPEUTICS
Patient Engagement in Gene and Cell Therapy: What is Different?
Boston, New York, United States
photo
Alan Hartman
PARTNER, CENTERVIEW PARTNERS
How to Get Acquired: What Companies Look for When in Acquisition Mode
photo
Paul Hastings
PRESIDENT AND CEO, NKARTA THERAPEUTICS
Understanding the Voices of Patients: Unique Perspectives on Healthcare
Diversity and Inclusion in Biotech’s Explosion: ERG and Non-Profit Perspectives
San Francisco, California, United States
photo
Richard Hatchett
CHIEF EXECUTIVE OFFICER , CEPI
A Way Forward: Winning the War on COVID through Vaccines
London , United Kingdom
photo
Rachel Haurwitz, PhD
PRESIDENT AND CEO, CARIBOU BIOSCIENCES
True North: Maintaining your vision and letting scientific innovation be your guide
Berkeley, California, United States
photo
Lou Hawthorne
CEO, NANOTICS, LLC
NaNotics, LLC
Mill Valley, California, United States
photo
Daria Hazuda
VP, INFECTIOUS DISEASES DISCOVERY & CHIEF SCIENTIFIC OFFICER, MRL CAMBRIDGE EXPLORATORY CENTER, MERCK & CO
Shifting the Treatment Paradigm: New tools to tackle antimicrobial resistance
Cambridge, Massachusetts, United States
photo
Mary Hecht-Kissel, MBA
DIRECTOR, BUSINESS DEVELOPMENT, NORTH CAROLINA BIOTECHNOLOGY CENTER
North Carolina – a global life science leader
Research Triangle Park, North Carolina, United States
photo
Brenda Hefti, JD, PhD
SENIOR VICE PRESIDENT, INTELLECTUAL PROPERTY AND LICENSING, EXELIXIS
GETTING TO YES: Negotiating IP Terms in Contracts
Alameda, California, United States
photo
Mo Heidaran
VICE PRESIDENT TECHNICAL, REGULATORY AND TECHNICAL CMC CONSULTING CELL, GENE THERAPY AND TISSUE ENGINEERING, PAREXEL INTERNATIONAL
Discover/Develop: But How Will you Manufacture Your Therapeutic?
photo
Abraham Heifets, PhD
CEO, CO-FOUNDER, ATOMWISE, INC.
Atomwise, Inc.
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
San Francisco, California, United States
photo
Per Hellsund, MBA
CEO, CYBREXA THERAPEUTICS
Getting to the Tumor: Beyond the First Generation of Tumor Targeting Technologies
Cybrexa Therapeutics
New Haven, Connecticut, United States
photo
Katherine High, MD
VISITING PROFESSOR; CO-FOUNDER AND FORMER PRESIDENT AND HEAD OF R&D, ROCKEFELLER UNIVERSITY; SPARK THERAPEUTICS
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Philadelphia, Pennsylvania, United States
photo
Quita Highsmith, MBA
CHIEF DIVERSITY OFFICER, GENENTECH
Can Precision Medicine Work for Everyone? Tackling the Challenge of Healthcare Disparities
South San Francisco, California, United States
photo
Jennifer Hinkel
HEALTH POLICY ADVISOR, VALUE BASED AGREEMENTS, NOVEL DRUG FINANCING, HEALTH DATA VALUATION
Get Engaged! How to Talk to ICER and Anyone Else Forming Opinions About Your Care Coverage
Washington, United States
photo
Seiji Hirasaki
CEO, ORICIRO GENOMICS
OriCiro Genomics
Tokyo, Japan
photo
William Ho
CHIEF EXECUTIVE OFFICER, INCYSUS THERAPEUTICS, INC.
Incysus Therapeutics, Inc.
NEW YORK, New York, United States
photo
Helen Ho, PhD
VICE PRESIDENT, HEAD OF CORPORATE DEVELOPMENT, BLUEPRINT MEDICINES
Licensing Clinical-Stage Assets to Greater China
photo
Michele Holcomb, PhD
EXECUTIVE VICE PRESIDENT, STRATEGY AND CORPORATE DEVELOPMENT, CARDINAL HEALTH
Rare Disease Therapies are No Longer Rare: Can the US Healthcare Reimbursement System Handle Chronic Treatments for Orphan Diseases
Ohio, United States
Natalie Holles
Natalie Holles
PRESIDENT AND CHIEF EXECUTIVE OFFICER, AUDENTES, AN ASTELLAS COMPANY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
photo
Andy Holt
VP BUSINESS DEVELOPMENT , ASKBIO
Askbio
RTP , North Carolina, United States
photo
Axel Hoos
SENIOR VICE PRESIDENT AND THERAPEUTIC AREA HEAD ONCOLOGY, GLAXO SMITH KLINE
Future of IO Checkpoint Combinations
Collegeville, Pennsylvania, United States
photo
Zachary Hornby
CEO, PRESIDENT AND DIRECTOR, BOUNDLESS BIO INC.
Looking for the Next Targeted Oncology Blockbuster
La Jolla, California, United States
photo
Ken Horne
PRESIDENT & COO, TEON THERAPEUTICS, INC.
Teon Therapeutics, Inc.
Redwood City, California, United States
photo
Dar-Jen Hsieh
CEO, ACRO BIOMEDICAL CO., LTD.
ACRO Biomedical Co., Ltd.
Kaohsiung City, Taiwan
photo
Pearl Huang, PhD
PRESIDENT AND CEO, CYGNAL THERAPEUTICS
Getting a seat at the table: how can new small companies enter the oncology space?
photo
Tom Hughes, PhD
CEO, NAVITOR PHARMACEUTICALS
Redefining What it Means to Get Old: New Breakthroughs in Aging Biology
Cambridge , Massachusetts, United States
photo
Kevin Kyung-Hwa Huh
VICE CHAIRMAN, KPBMA(KOREA PHARMACEUTICAL AND BIO-PHARMA MANUFACTURERS ASSOCIATION)
KPBMA(Korea Pharmaceutical and Bio-Pharma Manufacturers Association)
Seoul, Korea - South Korea
photo
Stephen Hurst, JD
CO-FOUNDER, EXECUTIVE CHAIRMAN AND CO-CEO, MIND MEDICINE
Disruptive Thinking: New Tools To Transform Addiction Treatment
Toronto, Ontario, Canada
photo
Patricia Hurter
CEO, LYNDRA THERAPEUTICS
Lyndra Therapeutics
Watertown , Massachusetts, United States
photo
Albert Hwang, MD
MANAGING DIRECTOR, HEALTHCARE, INVESTMENT BANKING, MORGAN STANLEY
Realizing the Promise of Gene Therapies for Patients Around the World: A Year of Progress
Load More